Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea
· Delayed Price · Currency is KRW
15,450
-250 (-1.59%)
At close: Dec 5, 2025
KRX:271980 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 225,130 | 166,115 | 249,173 | 306,279 | - | - | |
| Market Cap Growth | 10.52% | -33.33% | -18.64% | - | - | - | |
| Enterprise Value | 301,168 | 219,930 | 307,855 | 346,439 | - | - | |
| Last Close Price | 15450.00 | 11400.00 | 17100.00 | 20937.61 | 33666.10 | 62145.11 | |
| PE Ratio | 11.47 | - | 49.79 | - | - | - | |
| PS Ratio | 0.36 | 0.24 | 0.34 | 0.42 | - | - | |
| PB Ratio | 0.92 | 0.76 | 1.46 | 1.87 | - | - | |
| P/TBV Ratio | 1.15 | 0.91 | 1.62 | 1.99 | - | - | |
| P/OCF Ratio | - | 51.70 | - | - | - | - | |
| EV/Sales Ratio | 0.48 | 0.31 | 0.42 | 0.48 | - | - | |
| EV/EBITDA Ratio | 8.64 | - | 16.50 | - | - | - | |
| EV/EBIT Ratio | 13.18 | - | 34.64 | - | - | - | |
| Debt / Equity Ratio | 0.38 | 0.35 | 0.42 | 0.33 | 0.29 | 0.29 | |
| Debt / EBITDA Ratio | 2.67 | - | 3.82 | - | - | 2.30 | |
| Debt / FCF Ratio | - | - | - | - | 3.48 | - | |
| Asset Turnover | 1.25 | 1.39 | 1.54 | 1.64 | 1.68 | 1.71 | |
| Inventory Turnover | 3.84 | 4.92 | 5.19 | 5.61 | 5.15 | 5.53 | |
| Quick Ratio | 0.82 | 0.79 | 0.66 | 0.71 | 0.78 | 0.75 | |
| Current Ratio | 1.30 | 1.18 | 1.04 | 1.12 | 1.28 | 1.27 | |
| Return on Equity (ROE) | 13.46% | -15.45% | 3.11% | -9.06% | -8.82% | 4.08% | |
| Return on Assets (ROA) | 2.87% | -2.29% | 1.18% | -1.89% | -1.55% | 1.92% | |
| Return on Capital (ROIC) | 4.79% | -4.32% | 2.41% | -3.84% | -2.97% | 3.67% | |
| Return on Capital Employed (ROCE) | 8.80% | -7.90% | 4.90% | -6.80% | -5.10% | 6.50% | |
| Earnings Yield | 8.72% | -18.04% | 2.01% | -4.27% | - | - | |
| FCF Yield | -5.65% | -0.64% | -4.45% | -8.57% | - | - | |
| Dividend Yield | - | - | 0.29% | 0.24% | - | - | |
| Payout Ratio | - | - | 14.55% | - | - | 14.79% | |
| Buyback Yield / Dilution | -0.02% | - | 0.02% | 0.23% | 0.04% | 0.41% | |
| Total Shareholder Return | -0.02% | - | 0.31% | 0.47% | 0.04% | 0.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.